Cite
APA Citation
Lee, C., Motzer, R. J., Glen, H., Michaelson, M. D., Larkin, J., Minoshima, Y., Kanekiyo, M., Dairiki, R., Sachdev, P., Dutcus, C. E., Funahashi, Y., & Voss, M. H. (n.d.). 76PCorrelative analyses of serum biomarkers and efficacy outcomes in the randomized phase II trial of lenvatinib (LEN), everolimus (EVE), or LEN+EVE in patients with metastatic renal cell carcinoma. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095200168.0x00003e